Retinol binding protein 4, low birth weight-related insulin resistance and hormonal contraception

Antonella Zugaro1, Caterina Pandolfi, Arcangelo Barbonetti

  • 1Department of Internal Medicine and Public Health, University of L'Aquila, Coppito, 67100, L'Aquila, Italy.

Endocrine
|December 7, 2007
PubMed

Insights

Serum retinol binding protein 4 (RBP4) is not an early marker for insulin resistance in low birth weight women. However, hormonal contraception use is associated with increased RBP4 levels.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Reproductive Health

Background:

  • Retinol binding protein 4 (RBP4) is implicated as a potential early marker for insulin resistance (IR).
  • Low birth weight (LBW) is associated with increased risk of early-onset IR.
  • The relationship between RBP4, LBW, and IR requires further elucidation.

Purpose of the Study:

  • To investigate serum RBP4 levels in young women born with LBW as a model for early-onset IR.
  • To determine if LBW is associated with elevated RBP4 and reduced insulin sensitivity.
  • To explore factors associated with RBP4 levels in this population.

Main Methods:

  • A historical prospective study comparing 35 LBW women with 35 term appropriate for gestational age (AGA) controls.
  • Metabolic evaluation including the composite-insulin sensitivity index (composite ISI).
  • Serum RBP4 measurement using competitive enzyme-linked immunosorbent assay (ELISA).
  • Multivariate logistic regression analysis to identify factors associated with RBP4 levels.

Main Results:

  • Serum RBP4 levels were similar between LBW and term AGA groups.
  • LBW women exhibited significantly lower composite ISI, indicating IR.
  • Hormonal contraception (HC) use, but not birth weight or parental diabetes, was significantly associated with higher RBP4 levels (OR = 10.6).
  • Women using HC had higher RBP4, triglycerides, cholesterol, CRP, and SHBG, but similar composite ISI compared to non-users.

Conclusions:

  • Serum RBP4 is not a reliable marker for early insulin resistance in LBW young women.
  • Hormonal contraception use is associated with sustained increases in serum RBP4 levels.
  • The clinical and pathophysiological significance of elevated RBP4 under HC warrants further investigation.

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...